Rocco Savino

Prof. Rocco Savino


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1999 in Immunity
Verified
Journal Article
Closed access
RCRobyn Catlett-Falcone
Robyn Catlett-Falcone
TLTerry H Landowski
Terry H Landowski
MOMarc M Oshiro
Marc M Oshiro
JTJames Turkson
James Turkson
ALAlexander Levitzki
Alexander Levitzki
RJRichard Jove
Richard Jove

25 May 1999 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
GRGabriella Rizzuto
Gabriella Rizzuto
MCManuela Cappelletti
Manuela Cappelletti
DMDomenico Maione
Domenico Maione
RSRocco Savino
Rocco Savino
DLDomenico Lazzaro
Domenico Lazzaro
EFElena Fattori
Elena Fattori
We show that an electric treatment in the form of high-frequency, low-voltage electric pulses can increase more than 100-fold the production and secretion of a recombinant protein from mouse skeletal muscle. Therapeutical erythopoietin (EPO) levels were achieved in mice with a single injection of as little as 1 μg of plasmid DNA, and the increase in hematocrit after EPO production was stable and long-lasting. Pharmacological regulation through a tetracycline-inducible promoter allowed regulation of serum EPO and hematocrit levels. Tissue damage after stimulation was transient. The method described thus provides a potentially safe and low-cost treatment for serum protein deficiencies.

1 February 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
VSVolker Sandig
Volker Sandig
RYRima Youil
Rima Youil
ABAndrew J. Bett
Andrew J. Bett
LFLaura L. Franlin
Laura L. Franlin
MOMasanobu Oshima
Masanobu Oshima
CCC. Thomas Caskey
C. Thomas Caskey
Helper-dependent (HD) adenoviral vectors devoid of all viral coding sequences provide for safe and highly efficient gene transfer with long-lasting transgene expression. High titer stocks of HD vectors can be generated by using the cre-recombinase system. However, we have encountered difficulties with this system, including rearranged HD vectors and variable efficiency of HD vector rescue. These problems represent a major hindrance, particularly with regard to large-scale production. To overcome these limitations, we have modified the system in two ways: We constructed a new helper virus with a modified packaging signal and enhanced growth characteristics. We also redesigned the vector backbones by including noncoding adenovirus sequences adjacent to the right inverted terminal repeat and by incorporated a number of different segments of noncoding DNA of human origin as “stuffer.” Comparison of these vectors showed that the nature of the stuffer sequence affects replication of the HD vector. Optimization of the system resulted in a more robust and consistent production of HD vectors with low helper contamination and high in vivo potency.

1 September 2003 in Hepatology
Verified
Journal Article
Open access
PDF file
ABAlex Blindenbacher
Alex Blindenbacher
XWXueya Wang
Xueya Wang
ILIgor Langer
Igor Langer
RSRocco Savino
Rocco Savino
LTLuigi Terracciano
Luigi Terracciano
MHMarkus H. Heim
Markus H. Heim
The response to partial hepatectomy (PH) is impaired in interleukin 6 (IL–6)–deficient mice. IL–6 is well known for its role in the induction of the acute phase (AP) response, and the impairment of this response after surgery and hepatectomy could explain the defective hepatocyte regeneration. In addition, it was proposed that IL–6 has an important role in stimulating the reentry of quiescent cells into the cell cycle within the first 2 to 4 hours after PH. To further analyze the role for IL–6, we performed two third hepatectomies in wild–type mice, in IL–6 knockout (KO) mice, and in IL–6 KO mice that were treated 30 minutes before surgery with intravenous (IV) (short acting) or subcutaneous (SC) (long acting) injections of recombinant IL–6. The high postoperative mortality of IL–6–deficient mice could be completely prevented by SC, but not by IV IL–6 treatment, showing the requirement of a sustained action of IL–6. However, there is a subset of IL–6 KO mice that survives a PH in good health even without IL–6 treatment. When we analyzed these mice, we found an intact liver regeneration and no indication of a block in cell cycle reentry. We conclude that the major role of IL–6 is the induction of an adaptive response to PH that ensures body homeostasis and survival.

1 March 2008 in Cell Cycle
Verified
Journal Article
Closed access
Donatella MalangaDonatella Malanga
Donatella Malanga
MSMarianna Scrima
Marianna Scrima
CMCarmela De Marco
Carmela De Marco
FFFernanda Fabiani
Fernanda Fabiani
NRNicola De Rosa
Nicola De Rosa
GVGiuseppe Viglietto
Giuseppe Viglietto
Somatic mutation (E17K) that constitutively activates the protein kinase AKT1 has been found in human cancer patients. We determined the role of the E17K mutation of AKT1 in lung cancer, through sequencing of AKT1 exon 4 in 105 resected, clinically annotated non-small cell lung cancer specimens. We detected a missense mutations G->A transition at nucleotide 49 (that results in the E17K substitution) in two squamous cell carcinoma (2/36) but not in adenocarcinoma (0/53). The activity of the endogenous kinase carrying the E17K mutation immunoprecipitated by tumour tissue was significantly higher compared with the wild-type kinase immunoprecipitated by the adjacent normal tissue as determined both by in vitro kinase assay using a consensus peptide as substrate and by in vivo analysis of the phosphorylation status of AKT1 itself (pT308, pS473) or of known downstream substrates such as GSK3 (pS9/S22) and p27 (T198). Immunostaining or immunoblot analysis on membrane-enriched extracts indicated that the enhanced...

1 September 2013 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
LGL. Gallelli
L. Gallelli
Olimipio GalassoOlimipio Galasso
Olimipio Galasso
DFD. Falcone
D. Falcone
SSS. Southworth
S. Southworth
Marta GrecoMarta Greco
Marta Greco
GSGiovambattista De Sarro
Giovambattista De Sarro